06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 27, 2024, 13:16 | Insight
‘Cancer prevention should not be an afterthought, it should be the first line of defense.’ - Phil Castle
NCI Division of Cancer Prevention shared on LinkedIn:  “‘Cancer prevention should not be an afterthought,…
Jun 27, 2024, 12:56 | Blog
Supporting childhood cancer research - Children's Cancer Institute
Children's Cancer Institute shared on LinkedIn: "At Children's Cancer Institute, we believe that a life…
Jun 27, 2024, 12:50 | Blog
Last days to apply to the bringing research insights into clinical implementation conference - European School of Oncology
European School of Oncology shared on LinkedIn: "Last days to apply to the Bringing research…
Jun 27, 2024, 12:44 | Societies
Discuss the future of immuno-oncology with Agenus at ESMOGI24
Agenus shared on LinkedIn: "If you are a physician attending ESMOGI24 in Munich from June…
Jun 27, 2024, 12:42 | Insight
Transform workplace challenges and achievements into donations to help Conquer Kids Cancer - St. Baldrick's Foundation
St. Baldrick's Foundation shared on LinkedIn:  “Remember that hilarious episode of The Office where Andy…
Jun 27, 2024, 12:32 | Insight
Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525
Michael Klichinsky, Co-Founder and Chief Scientific Officer at Carisma Therapeutics, shared on LinkedIn: “We are…
Jun 27, 2024, 12:31 | Blog
Important innovations developed in LMICs - NCI Center for Global Health
NCI Center for Global Health shared on LinkedIn: "What is reciprocal innovation? A new article…
Jun 27, 2024, 12:27 | Career
Chengkai Dai was appointed as senior investigator for the NCI Mouse Cancer Genetics Program - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn:  “FACULTY NEWS: Congratulations to Chengkai…
Jun 27, 2024, 12:22 | Insight
One-of-a-kind global meeting in Yokohama, Japan - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: “Don't miss out on…
Jun 27, 2024, 12:11 | Insight
Patrick Forde: What is an acceptable rate of crossover?
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
All: 2742 Posts: 331 - 340
Special Coverage